|
CN104372039A
|
|
Two-enzyme method for preparing rosuvastatin intermediates with branched chains
|
|
CN104372040A
|
|
Continuous preparation method of statin pharmaceutical intermediate namely (R)-3-hydroxyethyl glutarate
|
|
CN104372041A
|
|
Whole cell catalytic preparation method of (S)-4-chloro-3-hydroxyethyl butyrate
|
|
CN104372038A
|
|
Two-step catalytic preparation method of (R)-4-cyan-3-hydroxyvinyl butyrate
|
|
CN104342417A
|
|
Aspergillus terreus-derived activity-enhanced acyltransferase mutant
|
|
CN104342412A
|
|
Ketoreductase mutant for producing (S)-4-chloro-3-hydroxy ethyl butyrate
|
|
CN104342460A
|
|
Method for preparing statin side chain intermediate by means of whole-cell catalysis
|
|
CN104342406A
|
|
Thermostability enhanced formate dehydrogenase mutant and preparation method thereof
|
|
CN104342411A
|
|
Activity enhanced ketoreductase mutant, coding sequence and preparation method thereof
|
|
CN104342483A
|
|
Rapid screening method for halohydrin dehalogenase
|
|
CN104342410A
|
|
Ketone reductase mutant and preparation method thereof
|
|
CN104293671A
|
|
Disruption method of recombinant escherichia coli
|
|
CN104293761A
|
|
Large-scale preservation method of escherichia coli recombinant enzyme liquid
|
|
CN104293668A
|
|
Recombinant escherichia coli high-density fermentation method
|
